The clinical- and cost-effectiveness of lenalidomide for multiple myeloma in people who have received at least one prior therapy: an evidence review of the submission from Celgene

Martin Hoyle, Gabriel Rogers, Ruth Garside, Tiffany Moxham, Ken Stein

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyThe National Institute for Health and Care Excellence (NICE)
Number of pages124
Publication statusPublished - 2008
Externally publishedYes

Cite this